STIM

Keith J. Sullivan

Known title: President and CEOCIK: 0001417973

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

STIM shifts focus from devices to psychedelic infrastructure. Neuronetics announced it is moving away from solely manufacturing its TMS device and is building a platform to support psychedelic therapies. The change aims to broaden the company's role in the emerging mental-health market. The stock is currently trading near its $1.19 support level and has an RSI of 25.4, indicating a low momentum environment.

this person other insiders at STIM

Transaction History

STIM▼ Sell$62K
STIM▲ Buy$0
STIM▼ Sell$11K
STIM▼ Sell$56K
STIM▼ Sell$64K
STIM▲ Buy$0
STIM▼ Sell$115K
STIM▼ Sell$114K
STIM▼ Sell$134K
STIM▼ Sell$46K
STIM▼ Sell$23K
STIM▼ Sell$23K
STIM▼ Sell$67K
STIM▼ Sell$67K
STIM▼ Sell$67K
STIM▼ Sell$71K
STIM▲ Buy$0
STIM▼ Sell$30K
STIM▼ Sell$30K
STIM▼ Sell$13K
STIM▼ Sell$13K
STIM▼ Sell$13K
STIM▼ Sell$76K
STIM▼ Sell$138K
STIM▲ Buy$0
STIM▲ Buy$198K
STIM▼ Sell$236K
STIM▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.